Free Trial

Veru (VERU) Competitors

Veru logo
$0.58 -0.05 (-7.89%)
(As of 11/15/2024 ET)

VERU vs. NUS, NATR, MED, XERS, EL, IPAR, PBH, HLF, USNA, and AKBA

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Xeris Biopharma (XERS), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), and Akebia Therapeutics (AKBA).

Veru vs.

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Nu Skin Enterprises has higher revenue and earnings than Veru. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Veru, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.97B0.19$8.60M-$2.07-3.66
Veru$16.30M5.24-$93.15M-$0.48-1.22

Nu Skin Enterprises received 241 more outperform votes than Veru when rated by MarketBeat users. However, 69.67% of users gave Veru an outperform vote while only 64.00% of users gave Nu Skin Enterprises an outperform vote.

CompanyUnderperformOutperform
Nu Skin EnterprisesOutperform Votes
512
64.00%
Underperform Votes
288
36.00%
VeruOutperform Votes
271
69.67%
Underperform Votes
118
30.33%

In the previous week, Nu Skin Enterprises had 1 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nu Skin Enterprises and 3 mentions for Veru. Veru's average media sentiment score of 1.17 beat Nu Skin Enterprises' score of 0.46 indicating that Veru is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nu Skin Enterprises
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veru
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nu Skin Enterprises has a net margin of -5.81% compared to Veru's net margin of -376.38%. Nu Skin Enterprises' return on equity of 5.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises-5.81% 5.47% 2.46%
Veru -376.38%-115.99%-66.94%

Nu Skin Enterprises currently has a consensus price target of $8.88, suggesting a potential upside of 17.08%. Veru has a consensus price target of $4.00, suggesting a potential upside of 585.40%. Given Veru's stronger consensus rating and higher probable upside, analysts plainly believe Veru is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Veru
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 1.7% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Nu Skin Enterprises has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Veru has a beta of -0.47, meaning that its share price is 147% less volatile than the S&P 500.

Summary

Nu Skin Enterprises and Veru tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$85.43M$6.53B$5.15B$8.74B
Dividend YieldN/A8.16%5.18%4.08%
P/E Ratio-1.224.9166.6713.57
Price / Sales5.24376.691,276.8487.67
Price / CashN/A51.2039.7035.24
Price / Book2.659.686.475.93
Net Income-$93.15M$154.43M$119.73M$225.73M
7 Day Performance-20.30%-9.46%-5.13%-1.34%
1 Month Performance-32.49%-7.27%-2.71%1.15%
1 Year Performance-45.20%28.13%31.08%24.02%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
2.6645 of 5 stars
$0.58
-7.9%
$4.00
+585.4%
-41.6%$85.43M$16.30M-1.22189Positive News
NUS
Nu Skin Enterprises
4.0068 of 5 stars
$7.22
+10.2%
N/A-57.3%$358.85M$1.78B-3.493,700
NATR
Nature's Sunshine Products
2.9504 of 5 stars
$17.43
+17.0%
N/A-7.1%$322.63M$445.32M19.81814Positive News
High Trading Volume
MED
Medifast
2.59 of 5 stars
$19.44
+1.5%
N/A-72.7%$212.53M$674.48M29.45870Positive News
XERS
Xeris Biopharma
4.0131 of 5 stars
$3.28
-5.5%
N/A+86.0%$488.72M$181.41M-7.29290Analyst Revision
News Coverage
EL
Estée Lauder Companies
4.8029 of 5 stars
$64.58
+1.1%
N/A-48.0%$23.18B$15.61B115.3262,000Short Interest ↑
IPAR
Inter Parfums
4.4285 of 5 stars
$128.80
+0.4%
N/A-1.8%$4.11B$1.42B27.64530Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
PBH
Prestige Consumer Healthcare
3.7771 of 5 stars
$81.75
+1.7%
N/A+39.6%$4.05B$1.13B19.89540Insider Selling
Analyst Revision
HLF
Herbalife
4.0638 of 5 stars
$8.67
+1.9%
N/A-37.6%$873.87M$5.00B10.209,200
USNA
USANA Health Sciences
2.8527 of 5 stars
$41.29
+2.6%
N/A-11.8%$786.99M$861.97M14.591,800
AKBA
Akebia Therapeutics
4.0701 of 5 stars
$1.99
+2.6%
N/A+81.0%$407.96M$194.62M-8.65167

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners